ATF4, DLX3, FRA1, MSX2, C/EBP-zeta, and C/EBP-alpha Shape the Molecular Basis of Therapeutic Effects of Zoledronic Acid in Bone Disorders

Marofi, F; Choupani, J; Solali, S; Vahedi, G; Hassanzadeh, A; Gharibi, T; Hagh, MF

Hagh, MF (corresponding author), Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz 5136944665, Iran.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2020; 20 (18): 2274